Healthcare - Biotechnology - NASDAQ - US
$ 1.59
-1.85 %
$ 43.6 M
Market Cap
-1.92
P/E
Price Target
Average
340.25%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
86.27%
Net Income
Estimate
50.05%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immix Biopharma, Inc.
Wall Street analysts predict an average 1-year price target for IMMX of $7 , with forecasts ranging from a low of $7 to a high of $7 .
IMMX Lowest Price Target
Wall Street Target
7 USD
340.25%
IMMX Average Price Target
Wall Street Target
7 USD
340.25%
IMMX Highest Price Target
Wall Street Target
7 USD
340.25%
REVENUE FORECAST
Revenue Forecast Chart IMMX
EBIT FORECAST
EBIT Forecast Chart IMMX
NET INCOME FORECAST
Net Income Chart IMMX